A new therapeutic candidate for breast cancer: laminin-332 overexpressing myofibroblast formation via epithelial-mesenchymal transition in the interface zone

被引：0
|
作者：
Kim, Baek Gil [1 ]
Kang, Suki [1 ]
Cho, Nam Hoon [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2011年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：207 / 208
页数：2
相关论文
共 50 条
  • [21] Pirfenidone Reduces Epithelial-Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs)
    Es, Hamidreza Aboulkheyr
    Cox, Thomas R.
    Sarafraz-Yazdi, Ehsan
    Thiery, Jean Paul
    Warkiani, Majid Ebrahimi
    CANCERS, 2021, 13 (20)
  • [22] WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition
    Chandra Prakash Prasad
    Shivendra Kumar Chaurasiya
    William Guilmain
    Tommy Andersson
    Journal of Experimental & Clinical Cancer Research, 35
  • [23] WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition
    Prasad, Chandra Prakash
    Chaurasiya, Shivendra Kumar
    Guilmain, William
    Andersson, Tommy
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [24] STAT1-HDAC4 signaling induces epithelial-mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2
    Kaowinn, Sirichat
    Kaewpiboon, Chutima
    Koh, Sang Seok
    Kraemer, Oliver H.
    Chung, Young-Hwa
    ONCOLOGY REPORTS, 2018, 40 (05) : 2619 - 2627
  • [25] Extracellular ATP promotes breast cancer invasion and epithelial-mesenchymal transition via hypoxia-inducible factor 2α signaling
    Yang, Hui
    Geng, Yue-Hang
    Wang, Peng
    Zhou, Yan-Ting
    Yang, Han
    Huo, Yan-Fei
    Zhang, Hong-Quan
    Li, Yan
    He, Hui-Ying
    Tian, Xin-Xia
    Fang, Wei-Gang
    CANCER SCIENCE, 2019, 110 (08) : 2456 - 2470
  • [26] High-dose vitamin C suppresses the invasion and metastasis of breast cancer cells via inhibiting epithelial-mesenchymal transition
    Zeng, Ling-Hui
    Wang, Qing-Mei
    Feng, Lin-Yi
    Ke, Yu-Dun
    Xu, Qian-Zi
    Wei, An-Yi
    Zhang, Chong
    Ying, Rong-Biao
    ONCOTARGETS AND THERAPY, 2019, 12 : 7405 - 7413
  • [27] EGFR inhibition reverses epithelial-mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells
    Takeda, Tomoya
    Tsubaki, Masanobu
    Matsuda, Takuya
    Kimura, Akihiro
    Jinushi, Minami
    Obana, Teruki
    Takegami, Manabu
    Nishida, Shozo
    ONCOLOGY REPORTS, 2022, 47 (06)
  • [28] Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer
    Wang, Haiji
    Xu, Chunyuan
    Kong, Xiaoli
    Li, Xiaoyan
    Kong, Xiangnan
    Wang, Yu
    Ding, Xia
    Yang, Qifeng
    PLOS ONE, 2014, 9 (06):
  • [29] Cancer Susceptibility Candidate 9 (CASC9) Promotes Colorectal Cancer Carcinogenesis via mTOR-Dependent Autophagy and Epithelial-Mesenchymal Transition Pathways
    Khan, Md Zahirul Islam
    Law, Helen Ka Wai
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [30] Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway
    Guo, Zhiying
    Zhao, Ming
    Howard, Erin W.
    Zhao, Qingxia
    Parris, Amanda B.
    Ma, Zhikun
    Yang, Xiaohe
    ONCOTARGET, 2017, 8 (36) : 60342 - 60357
12345